Personalized approach to the selection of standard and targeted therapies in metastatic colorectal cancer

被引：0
|
作者：
Engel, R. [1 ,2 ]
Boka, H. [2 ]
Archer, S. [5 ]
Nguyen, S. [3 ]
Nickless, D. [4 ]
Niap, A. [4 ]
Plazzer, J. P. [1 ]
Georges, C. [1 ]
Fennell, L. [2 ]
Skinner, L. [2 ]
Mcmurrick, P. [1 ]
Abud, H. [2 ]
机构：
[1] Cabrini Monash Univ, Cabrini Hlth, Dept Surg, Melbourne, Vic, Australia
[2] Monash Biomed Discovery Inst, Dept Anat & Dev Biol, Clayton, Vic, Australia
[3] Cabrini Hosp, IMED Radiol Network, Melbourne, Vic, Australia
[4] Cabrini Hosp, Dept Anat Pathol, Melbourne, Vic, Australia
[5] Monash Univ, Monash Bioinformat Platform, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
326
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [21] Targeted Therapies for Metastatic Esophagogastric Cancer
    Deepa Reddy
    Zev A. Wainberg
    Current Treatment Options in Oncology, 2011, 12 : 46 - 60
  • [22] Targeted therapies and radiotherapy in colorectal cancer
    Azria, D
    Magné, N
    BULLETIN DU CANCER, 2005, 92 : S37 - S43
  • [23] Responses to targeted therapies: colorectal cancer
    Bibeau, Frederic
    Frugier, Helene
    Boissiere-Michot, Florence
    ANNALES DE PATHOLOGIE, 2009, 29 : S74 - S76
  • [24] Targeted therapies in the management of Colorectal cancer
    Maughan, Tim
    JOURNAL OF MEDICAL GENETICS, 2011, 48 : S26 - S26
  • [25] The Evolving Personalized Landscape of Colorectal Cancer Therapies
    Anker, Christopher J.
    Buckstein, Michael H.
    Chuong, Michael D.
    Hawkins, Maria A.
    Kharofa, Jordan
    Raldow, Ann C.
    Tait, Diana
    Olsen, Jeffrey R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05): : 1255 - 1262
  • [26] Personalized and targeted therapies
    Wisniewska, Magdalena
    Wisniewski, Michal
    Lewandowska, Marzena A.
    PHYSICAL SCIENCES REVIEWS, 2021, : 2103 - 2126
  • [27] Efficacy of targeted therapies metastatic colorectal cancer: systematic review and meta-analysis
    Gouverneur, A.
    Arnaud, M.
    Berdai, D.
    De Boissieu, P.
    Fourrier-Reglat, A.
    Noize, P.
    Salvo, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 8 - 8
  • [28] Survival determinants with matched targeted therapies in BRAF mutant metastatic colorectal cancer (mCRC).
    Sanz-Garcia, Enrique
    Martinez, Ana Maria
    Elez, Elena
    Argiles, Guillem
    Grasselli, Julieta
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Sauri, Tamara
    Hierro, Cinta
    Matos, Ignacio
    Verdaguer, Helena
    Azaro, Analia
    Landolfi, Stefania
    Hernandez-Losa, Javier
    Rodon, Jordi
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [29] Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
    Dazio, Giulia
    Epistolio, Samantha
    Frattini, Milo
    Saletti, Piercarlo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [30] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab
    Tonini, Giuseppe
    Calvieri, Alice
    Vincenzi, Bruno
    Santini, Daniele
    ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82
12345